Global HIV & AIDS statistics — Fact sheet

Global HIV statistics

  • 39 million [33.1 million–45.7 million] people globally were living with HIV in 2022.
  • 1.3 million [1 million–1.7 million] people became newly infected with HIV in 2022.
  • 630 000 [480 000–880 000] people died from AIDS-related illnesses in 2022.
  • 29.8 million people were accessing antiretroviral therapy in 2022.
  • 85.6 million [64.8 million–113.0 million] people have become infected with HIV and 40.4 million [32.9 million–51.3 million] people have died from AIDS-related illnesses since the start of the epidemic.

People living with HIV

  • In 2022, there were 39 million [33.1 million–45.7 million] people living with HIV.
    • 37.5 million [31.8 million–43.6 million] adults (15 years or older).
    • 1.5 million [1.2 million–2.1 million] children (0–14 years).
    • 53% of all people living with HIV were women and girls.
  • 86% [73– >98%] of all people living with HIV knew their HIV status in 2022.

People living with HIV accessing antiretroviral therapy

  • At the end of December 2022, 29.8 million people (76% [65–89%] of all people living with HIV) were accessing antiretroviral therapy, up from 7.7 million in 2010.
    • 77% [65–90%] of adults aged 15 years and older had access to treatment; however, just 57% [44–78%] of children aged 0–14 years had access.
    • 82% [69–95%] of women aged 15 years and older had access to treatment; however, just 72% [60–84%] of men aged 15 years and older had access.
    • 82% [64–98%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2022.
  • 9.2 million people living with HIV did not have access to antiretroviral treatment in 2022.

New HIV infections

  • New HIV infections have been reduced by 59% since the peak in 1995.
    • In 2022, 1.3 million [1 million–1.7 million] people were newly infected with HIV, compared to 3.2 million [2.5 million–4.3 million] people in 1995.
    • Women and girls accounted for 46% of all new infections in 2022.
  • Since 2010, new HIV infections have declined by 38%, from 2.1 million [1.6 million–2.8 million] to 1.3 million [1 million–1.7 million] in 2022.
  • Since 2010, new HIV infections among children have declined by 58%, from 310 000 [210 000–490 000] in 2010 to 130 000 [90 000–210 000] in 2022.

AIDS-related deaths

  • AIDS-related deaths have been reduced by 69% since the peak in 2004 and by 51% since 2010.
  • In 2022, around 630 000 [480 000–880 000] people died from AIDS-related illnesses worldwide, compared to 2.0 million [1.5 million–2.8 million] people in 2004 and 1.3 million [970 000–1.8 million] people in 2010.
  • AIDS-related mortality has declined by 55% among women and girls and by 47% among men and boys since 2010.

Women and girls

  • Globally 46% of all new HIV infections were among women and girls in 2022.
  • In sub-Saharan Africa, adolescent girls and young women accounted for more than 77% of new infections among young people aged 15-24 years in 2022.
  • In sub-Saharan Africa adolescent girls and young women (aged 15-24 years) in were more than three times as likely to acquire HIV than their male peers in 2022. 
  • Every week, 4000 adolescent girls and young women aged 15–24 years became infected with HIV globally in 2022. 3100 of these infections occurred in sub-Saharan Africa.
  • Only about 42% of districts with high HIV incidence in sub-Saharan Africa had dedicated HIV prevention programmes for adolescent girls and young women in 2021.

Key populations

  • Globally, median HIV prevalence among the adult population (ages 15-49) was 0.7%. However median prevalence was higher among key populations:
    • 2.5% among sex workers
    • 7.5% among gay men and other men who have sex with men
    • 5.0% among people who inject drugs
    • 10.3% among transgender persons
    • 1.4% among people in prisons.

Testing and treatment targets (95–95–95)

  • In 2022, 86% [73– >98%] of all people living with HIV knew their HIV status. Among people who knew their status, 89% [75– >98%] were accessing treatment. And among people accessing treatment, 93% [79– >98%] were virally suppressed.
  • Among all people living with HIV, 86% [73– >98%] knew their status, 76% [65–89%] were accessing treatment and 71% [60–83%] were virally suppressed in 2022.
  • Five countries— Botswana, Eswatini, Rwanda, the United Republic of Tanzania, and Zimbabwe had achieved the 95-95-95 targets by 2022.

Funding

  • A total of US$ 20.8 billion (constant 2019 US$) was available for HIV programmes in low- and middle-income countries in 2022––2.6% less than in 2021 and well short of the US$ 29.3 billion needed by 2025.
  • Around 60% of resources available in 2022 were sourced domestically, compared with around 50% in 2010.
  • The reduction in resources available for HIV in 2022 is due to declines in both international and domestic funding. The US$ 8.3 billion of external HIV funding in 2022 was 3% lower than in 2021. At the same time, domestic funding is diminishing.
  • Bilateral funding from the United States Government constituted 58% of all international assistance for HIV, while disbursements from the Global Fund to Fight AIDS, Tuberculosis and Malaria accounted for about 29%. Other international donors contributed the remainder, but that share has diminished considerably, from approximately US$ 3 billion in 2010 to US$ 1.2 billion in 2022, a 61% decrease.
  • In 2022, there was an estimated 90% funding gap for HIV prevention programmes among people from key populations, compared with the funding needed by 2025.

Download the full version to view regional statistics, global and regional data

HIV estimates with uncertainty bounds 1990-Present

Download spreadsheet (updated 31 Aug 2023)

Tuberculosis fact sheet